Russian Tobacco Tax Applies to LPR and DPR

Dec.26.2022

Russian Tobacco Tax Applies to LPR and DPR

From January 1st, tobacco consumption tax will be levied in LPR, DPR, Zaporozhye, and Kherson regions under Russian tax law.

Starting from January 1, LPR, DPR, Zaporozhye, and Kherson regions will levy a tobacco consumption tax in accordance with the tax laws of the Russian Federation.

Image source: Russian Soyuz-Nicudin alliance.

Tobacco product manufacturers within the dependent territories must complete a residue check by the end of the year and submit a report to the Federal Tax Bureau by February 1, 2023.

From September 1 to December 31, 2023, the coefficient T and Tb for cigarette, cigarillo, bidi, and clove cigarette manufacturers are set to 1.

#E-cigarette Taxes #USA

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

2026 InterTabac Special Coverage

2026 InterTabac Special Coverage

FDA Adds 18 Tobacco Harmful Constituents and Seeks Comment on 3 More

FDA Adds 18 Tobacco Harmful Constituents and Seeks Comment on 3 More

U.S. Food and Drug Administration published a Federal Register notice finalizing the addition of 18 constituents to the established list of Harmful and Potentially Harmful Constituents in tobacco products. With the update, the list now contains 111 constituents. FDA also proposed adding three more constituents to the list and opened a public comment period ending at 11:59 p.m. ET on May 26, 2026.

Apr.24 by 2FIRSTS.ai

KT&G Q1 2026 Financial Results: Revenue at $1.156 Billion, E-Cigarettes to Launch Independent Overseas Expansion

KT&G Q1 2026 Financial Results: Revenue at $1.156 Billion, E-Cigarettes to Launch Independent Overseas Expansion

KT&G reports a 27.6% increase in Q1 operating profit, with traditional and new tobacco sectors driving growth.

May.07 by 2FIRSTS.ai

FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files

FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files

FDA’s Center for Tobacco Products and NIH’s National Institute on Drug Abuse announced that new Wave 8 restricted-use data files from the PATH Study are now available. The files contain data collected between January 2024 and December 2024, including questionnaire data, location characteristics data, and state identifier data.

Apr.17 by 2FIRSTS.ai

FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications

FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications

The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.

Exclusive｜Logistics Operators Warn of Possible New U.S. Border Crackdown on Illicit Vapes

Exclusive｜Logistics Operators Warn of Possible New U.S. Border Crackdown on Illicit Vapes

Recent inspections and cargo disruption have led some logistics operators in the China-U.S. vape trade to see early signs of another U.S. border crackdown on illicit e-cigarettes. With late April to early May viewed as a key risk window, the market is watching closely. The bigger question is not only whether enforcement will tighten, but whether it can be sustained.

Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS

Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS

Altria Group reported its first-quarter 2026 results on April 30. Net revenues were $5.43 billion, up 3.2% year on year, while revenues net of excise taxes were $4.76 billion, up 5.3%. Reported diluted EPS was $1.30, up more than 100%, and adjusted diluted EPS was $1.32, up 7.3%.

May.06 by 2FIRSTS.ai

Related Topics

News

Related Read

FDA Adds 18 Tobacco Harmful Constituents and Seeks Comment on 3 More

FDA Adds 18 Tobacco Harmful Constituents and Seeks Comment on 3 More

KT&G Q1 2026 Financial Results: Revenue at $1.156 Billion, E-Cigarettes to Launch Independent Overseas Expansion

KT&G Q1 2026 Financial Results: Revenue at $1.156 Billion, E-Cigarettes to Launch Independent Overseas Expansion

FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files

FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files

FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications

FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications

Exclusive｜Logistics Operators Warn of Possible New U.S. Border Crackdown on Illicit Vapes

Exclusive｜Logistics Operators Warn of Possible New U.S. Border Crackdown on Illicit Vapes

Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS

Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS